Vaccine-Preventable Diseases and the Newborn Infant: The Roles of Serologic Testing and Maternal Vaccination

Originally presented on March 23, 2017

Speaker:
Robert M Jacobson, MD, FAAP
Medical Director, Mayo Clinic’s Primary Care Immunization Program

The goal of this webinar is to demonstrate the impact of diseases such as Hepatitis B, pertussis, flu, etc. on an infant and why it is critical to improving maternal immunization rates.

Learning Outcome
As a result of this activity, the learner will be able to enhance their knowledge and competence on the impact of diseases on an infant and why it is critical to improving maternal immunization rates.

Learning Objectives
After watching this webinar participants will be able to:

  • Identify vaccine-preventable diseases and the need for prenatal screening for serological immunity and vaccination status in each pregnancy
  • Describe the burden of vaccine-preventable diseases on newborns and infants
  • Recognize the importance from a pediatric perspective about the benefits of maternal immunization

Content Note for slides 29 & 30: Since the airing of this webinar, additional guidance has been released by the CDC for babies weighing less than 2,000 grams.

For infants weighing <2,000 grams, the birth dose (i.e., the initial HepB vaccine dose) should not be counted as part of the vaccine series because of the potentially reduced immunogenicity of HepB vaccine in these infants.  3 additional doses of vaccine (for a total of 4 doses) should be administered beginning when the infant reaches age 1 month. The final dose in the series should not be administered before age 24 weeks (164 days).

MMWR containing the ACIP Hepatitis B Recommendations are available at: https://www.cdc.gov/mmwr/volumes/67/rr/rr6701a1.htm?s_cid=rr6701a1_w

Target Audience:
Clinicians in ob-gyn practices including physicians, nurse practitioners, physician assistants, nurse managers, etc.


To Obtain Continuing Education Credits:

Each participant interested in CE credits must complete an evaluation and post-test, which is available above under "Evaluation, Post-test & Credits". A score of 80% and above on the post-test will generate a certificate indicating the requested credits.

Be sure to type in your e-mail correctly to receive the link to your certificate.


Dr. Jacobson has expressed the following potential conflicts of interest:

  • Safety Review Committee
    • - Gardasil  or 4-valent human papillomavirus vaccine in males (Merck)
    • - Gardasil®9  or 9-valent human papillomavirus vaccine (Merck)
  • Data and Safety Monitoring Board
    • - Adult and infant 15-valent pneumococcal conjugate vaccine (Merck)
  • No off-label use discussion

All relevant financial relationships have been mitigated.

The other planners, and moderator do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in this activity.

No commercial funding has been accepted for this activity.


Continuing Medical Education Credits

The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

The School of Public Health, University at Albany designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Medical Education Credits are offered until May 31, 2023.


Continuing Nurse Education Contact Hours

The University at Albany School of Public Health is approved as a provider of nursing continuing professional development by the Northeast Multistate Division, an accredited approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This offering is approved for 1 nursing contact hour(s).

Nursing Contact Hours are offered until May 31, 2023.


Certified Health Education Specialist Contact Hours

Sponsored by the School of Public Health, University at Albany, SUNY, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I contact education contact hours. Maximum advanced-level continuing education contact hours available are 0. Continuing Competency credits available are 1.0. Provider ID# 99086.

Continuing Education Contact Hours are offered until May 31, 2023.